ECB-ART-51972
Front Med (Lausanne)
2023 Jan 01;10:1031998. doi: 10.3389/fmed.2023.1031998.
Show Gene links
Show Anatomy links
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease.
Lenti MV
,
Scribano ML
,
Biancone L
,
Ciccocioppo R
,
Pugliese D
,
Pastorelli L
,
Fiorino G
,
Savarino E
,
Caprioli FA
,
Ardizzone S
,
Fantini MC
,
Tontini GE
,
Orlando A
,
Sampietro GM
,
Sturniolo GC
,
Monteleone G
,
Vecchi M
,
Kohn A
,
Daperno M
,
D'Incà R
,
Corazza GR
,
Di Sabatino A
.
???displayArticle.abstract???
Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is a complex, immune-mediated, disorder which leads to several gastrointestinal and systemic manifestations determining a poor quality of life, disability, and other negative health outcomes. Our knowledge of this condition has greatly improved over the last few decades, and a comprehensive management should take into account both biological (i.e., disease-related, patient-related) and non-biological (i.e., socioeconomic, cultural, environmental, behavioral) factors which contribute to the disease phenotype. From this point of view, the so called 4P medicine framework, including personalization, prediction, prevention, and participation could be useful for tailoring ad hoc interventions in IBD patients. In this review, we discuss the cutting-edge issues regarding personalization in special settings (i.e., pregnancy, oncology, infectious diseases), patient participation (i.e., how to communicate, disability, tackling stigma and resilience, quality of care), disease prediction (i.e., faecal markers, response to treatments), and prevention (i.e., dysplasia through endoscopy, infections through vaccinations, and post-surgical recurrence). Finally, we provide an outlook discussing the unmet needs for implementing this conceptual framework in clinical practice.
???displayArticle.pubmedLink??? 37113615
???displayArticle.link??? Front Med (Lausanne)
References [+] :
Aberra,
Risk for active tuberculosis in inflammatory bowel disease patients.
2007, Pubmed
Aberra, Risk for active tuberculosis in inflammatory bowel disease patients. 2007, Pubmed
Abraham, Inflammatory bowel disease. 2009, Pubmed
Abraham, Fecal markers: calprotectin and lactoferrin. 2012, Pubmed
Adamina, ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment. 2020, Pubmed
Agrawal, Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User's Guide for Adult and Pediatric Gastroenterologists. 2021, Pubmed
Ahmed, Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. 2022, Pubmed
Al-Bawardy, Novel and Emerging Therapies for Inflammatory Bowel Disease. 2021, Pubmed
Alexakis, Perspectives and attitudes of young patients with inflammatory bowel disease: symptoms, burden of disease and communication with their healthcare professionals. 2014, Pubmed
Allen, Preventing disability in inflammatory bowel disease. 2017, Pubmed
Ananthakrishnan, Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases. 2017, Pubmed
Ananthakrishnan, Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities. 2017, Pubmed
André, C-reactive protein as a predictor of relapse in asymptomatic patients with Crohn's disease. 1983, Pubmed
Angelison, Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients. 2017, Pubmed
Annese, European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. 2015, Pubmed
Ardizzone, Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. 2006, Pubmed
Armuzzi, Female reproductive health and inflammatory bowel disease: A practice-based review. 2022, Pubmed
Atreya, In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease. 2014, Pubmed
Axelrad, Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents. 2016, Pubmed
Baars, Patients' preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment study. 2010, Pubmed
Bar-Gil Shitrit, Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study. 2019, Pubmed
Barberio, Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. 2021, Pubmed
Barberio, Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis. 2021, Pubmed
Bartels, Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. 2012, Pubmed
Beaugerie, Cancers complicating inflammatory bowel disease. 2015, Pubmed
Beaugerie, Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer. 2014, Pubmed
Beaugerie, Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. 2009, Pubmed
Beelen, Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials. 2022, Pubmed
Beltrán, Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease. 2019, Pubmed
Bemelman, ECCO-ESCP Consensus on Surgery for Crohn's Disease. 2018, Pubmed
Ben-Horin, Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials. 2022, Pubmed
Bernstein, Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. 2011, Pubmed
Bertani, Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab. 2020, Pubmed
Beswick, Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study. 2018, Pubmed
Biancone, Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. 2006, Pubmed
Billioud, Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review. 2011, Pubmed
Bodini, Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index. 2017, Pubmed
Bonovas, Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis. 2016, Pubmed
Borren, Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort Study. 2021, Pubmed
Bortoli, Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. 2011, Pubmed
Bossuyt, Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density. 2020, Pubmed
Bossuyt, Computer-Aided Diagnosis With Monochromatic Light Endoscopy for Scoring Histologic Remission in Ulcerative Colitis. 2021, Pubmed
Branche, Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy. 2009, Pubmed
Buisson, Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases. 2019, Pubmed
Burisch, Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study. 2014, Pubmed
Bzdok, Statistics versus machine learning. 2018, Pubmed
Card, Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data. 2020, Pubmed
Chande, Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. 2016, Pubmed
Chande, Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. 2015, Pubmed
Chaparro, Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. 2018, Pubmed
Chaparro, Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients. 2013, Pubmed
Chen, Application of Artificial Intelligence to Clinical Practice in Inflammatory Bowel Disease - What the Clinician Needs to Know. 2022, Pubmed
Chew, Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease. 2018, Pubmed
Christensen, Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement. 2022, Pubmed
Ciccocioppo, Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement. 2015, Pubmed
Ciccocioppo, Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis. 2021, Pubmed
Clowse, Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis. 2016, Pubmed
Cococcia, Validation of the Italian translation of the perceived stigma scale and resilience assessment in inflammatory bowel disease patients. 2021, Pubmed
Coffey, Inclusion of the Mesentery in Ileocolic Resection for Crohn's Disease is Associated With Reduced Surgical Recurrence. 2018, Pubmed
Cohn, Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). 2013, Pubmed
Colombel, Infliximab, azathioprine, or combination therapy for Crohn's disease. 2010, Pubmed
Colombel, The safety of vedolizumab for ulcerative colitis and Crohn's disease. 2017, Pubmed
Colombel, Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. 2017, Pubmed
Colombo, Restorative Proctocolectomy in Elderly IBD Patients: A Multicentre Comparative Study on Safety and Efficacy. 2017, Pubmed
Connor, Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). 2003, Pubmed
Corazza, Bringing complexity into clinical practice: An internistic approach. 2019, Pubmed
Corrigan, Understanding the impact of stigma on people with mental illness. 2002, Pubmed
Costa, Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. 2005, Pubmed
Cottone, Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. 2011, Pubmed
Cristaldi, Long-term results and multivariate analysis of prognostic factors in 138 consecutive patients operated on for Crohn's disease using "bowel-sparing" techniques. 2000, Pubmed
D'Haens, Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins. 2020, Pubmed
D'Haens, Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. 2008, Pubmed
D'Incà, Can calprotectin predict relapse risk in inflammatory bowel disease? 2008, Pubmed
Dahlén, Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy. 2015, Pubmed
Dayharsh, Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. 2002, Pubmed
Diederen, Raised faecal calprotectin is associated with subsequent symptomatic relapse, in children and adolescents with inflammatory bowel disease in clinical remission. 2017, Pubmed
Drossman, The rating form of IBD patient concerns: a new measure of health status. 1991, Pubmed
European Association For The Study Of The Liver, EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. 2012, Pubmed
Everhov, Women's Earnings are more Affected by Inflammatory Bowel Disease than Men's: A Register-Based Swedish Cohort Study. 2021, Pubmed
Facchin, Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients. 2021, Pubmed
Feagan, Vedolizumab as induction and maintenance therapy for ulcerative colitis. 2013, Pubmed
Feagan, Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. 2016, Pubmed
Ferreiro-Iglesias, Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study. 2018, Pubmed
Ferretti, An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis. 2022, Pubmed
Fiorino, The new frontier: Certifying quality standards in the inflammatory bowel disease care. 2021, Pubmed
Fiorino, 'Quality of Care' Standards in Inflammatory Bowel Disease: A Systematic Review. 2019, Pubmed
Fiorino, Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn's and Colitis Organisation [ECCO] Position Paper. 2020, Pubmed
Flores, P4 medicine: how systems medicine will transform the healthcare sector and society. 2013, Pubmed
Forbes, The effects of a promoter of cell differentiation and selected hormones on human cytomegalovirus infection using an in vitro cell system. 1990, Pubmed
Frontali, Segmental Colectomy for Ulcerative Colitis: Is There a Place in Selected Patients Without Active Colitis? An International Multicentric Retrospective Study in 72 Patients. 2020, Pubmed
Frontali, Acute severe ulcerative colitis: How to reduce operating time under 150 min for emergency laparoscopic colectomy - a video vignette. 2021, Pubmed
GBD 2017 Inflammatory Bowel Disease Collaborators, The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. 2020, Pubmed
Gallinger, Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease. 2016, Pubmed
Gaujoux, Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD. 2019, Pubmed
Ghanei Gheshlagh, Resilience of Patients With Chronic Physical Diseases: A Systematic Review and Meta-Analysis. 2016, Pubmed
Ghosh, Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases. 2017, Pubmed
Gisbert, Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice. 2020, Pubmed
Glass, Shared decision making and other variables as correlates of satisfaction with health care decisions in a United States national survey. 2012, Pubmed
Gonczi, Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role? 2017, Pubmed
Gottlieb, Central Reading of Ulcerative Colitis Clinical Trial Videos Using Neural Networks. 2021, Pubmed
Green, Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. 2013, Pubmed
Guillo, Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide. 2022, Pubmed
Hamdeh, Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis. 2020, Pubmed
Hanauer, Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary. 2019, Pubmed
Harrison, Epidemiological profile of meningococcal disease in the United States. 2010, Pubmed
Ho, Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis. 2009, Pubmed
Hong, Ustekinumab and Vedolizumab Are Not Associated With Subsequent Cancer in IBD Patients with Prior Malignancy. 2022, Pubmed
Hwang, Depression and resilience in ulcerative colitis and Crohn's disease patients with ostomy. 2019, Pubmed
Iacucci, Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study. 2023, Pubmed
Iacucci, An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis. 2021, Pubmed
Iacucci, A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis. 2023, Pubmed
Iacucci, Improving the quality of surveillance colonoscopy in inflammatory bowel disease. 2019, Pubmed
Inamdar, Smoking and early infliximab response in Crohn’s disease: a meta-analysis. 2015, Pubmed
Jarvis, Human cytomegalovirus persistence and latency in endothelial cells and macrophages. 2002, Pubmed
Jharap, Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts. 2010, Pubmed
Jones, Development and initial validation of a measure of perceived stigma in irritable bowel syndrome. 2009, Pubmed
Jürgens, Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease. 2011, Pubmed
Kabir, Systematic review with meta-analysis: IBD-associated colonic dysplasia prognosis in the videoendoscopic era (1990 to present). 2020, Pubmed
Kane, Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. 2008, Pubmed
Kanis, Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study. 2017, Pubmed
Kayal, Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability. 2022, Pubmed
Keller, Virus-specific T-cell therapies for patients with primary immune deficiency. 2020, Pubmed
Kirman, Infliximab: mechanism of action beyond TNF-alpha neutralization in inflammatory bowel disease. 2004, Pubmed
Kittanakom, Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease. 2017, Pubmed
Kobayashi, Ulcerative colitis. 2020, Pubmed
Kono, Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study. 2001, Pubmed
Kotlyar, A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. 2011, Pubmed
Kotton, The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. 2018, Pubmed
Kucharzik, ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. 2021, Pubmed
Kurt, Faecal incontinence in inflammatory bowel disease: The Nancy experience. 2022, Pubmed
Laharie, Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study. 2011, Pubmed
Lasa, Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. 2022, Pubmed
Le Berre, Application of Artificial Intelligence to Gastroenterology and Hepatology. 2020, Pubmed
Lebel, Stigma in cancer patients whose behavior may have contributed to their disease. 2008, Pubmed
Lenti, Intestinal fibrosis. 2019, Pubmed
Lenti, Stigmatisation and resilience in inflammatory bowel disease. 2020, Pubmed
Leso, Inflammatory bowel diseases and work disability: a systematic review of predictive factors. 2021, Pubmed
Lichtenstein, Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report. 2018, Pubmed
Lichtenstein, Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry. 2014, Pubmed
Lichtenstein, Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry. 2012, Pubmed
Limdi, Real-time use of artificial intelligence at colonoscopy predicts relapse in ulcerative colitis: predicting with "intelligence". 2022, Pubmed
Lin, Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. 2014, Pubmed
Linn, Talking about Dr. Google: Communication strategies used by nurse practitioners and patients with inflammatory bowel disease in the Netherlands to discuss online health information. 2020, Pubmed
Loewendorf, Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. 2010, Pubmed
Louis, A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism. 2002, Pubmed
Louis, Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. 2004, Pubmed
Luber, Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases? 2019, Pubmed
Luglio, Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease: The SuPREMe-CD Study - A Randomized Clinical Trial. 2020, Pubmed
Maaser, ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. 2019, Pubmed
MacDonald, Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease. 2016, Pubmed
Macaluso, Vaccinations in patients with inflammatory bowel disease. 2021, Pubmed
Macedo, Building resilience for future adversity: a systematic review of interventions in non-clinical samples of adults. 2014, Pubmed
Maconi, CARD15 gene variants and risk of reoperation in Crohn's disease patients. 2009, Pubmed
Maeda, Use of advanced endoscopic technology for optical characterization of neoplasia in patients with ulcerative colitis: Systematic review. 2022, Pubmed
Maeda, Can artificial intelligence help to detect dysplasia in patients with ulcerative colitis? 2021, Pubmed
Mahadevan, Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. 2019, Pubmed
Mahadevan, Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease. 2021, Pubmed
Mahadevan, Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis. 2018, Pubmed
Mahajan, Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. 2008, Pubmed
Mao, Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies. 2012, Pubmed
Mao, Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis. 2017, Pubmed
Marinelli, Sleep disturbance in Inflammatory Bowel Disease: prevalence and risk factors - A cross-sectional study. 2020, Pubmed
Marinelli, Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients. 2019, Pubmed
Marinelli, Factors associated with disability in patients with ulcerative colitis: A cross-sectional study. 2020, Pubmed
Mazzola, Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease. 2017, Pubmed
Minar, Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab. 2019, Pubmed
Mineccia, Has the Removing of the Mesentery during Ileo-Colic Resection an Impact on Post-Operative Complications and Recurrence in Crohn's Disease? Results from the Resection of the Mesentery Study (Remedy). 2022, Pubmed
Moens, Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab. 2019, Pubmed
Moens, Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. 2020, Pubmed
Moffett, The standard of care: legal history and definitions: the bad and good news. 2011, Pubmed
Molendijk, Disappointing durable remission rates in complex Crohn's disease fistula. 2014, Pubmed
Murata, Switching of EBV cycles between latent and lytic states. 2014, Pubmed
Murthy, AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review. 2021, Pubmed
Naismith, A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease. 2014, Pubmed
Nardone, PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis. 2022, Pubmed
Narula, Does smoking reduce infliximab's effectiveness against Crohn's disease? 2009, Pubmed
Nguyen, The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. 2016, Pubmed
Nielsen, Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis. 2022, Pubmed
Nyboe Andersen, Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease. 2014, Pubmed
Odufalu, Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry. 2022, Pubmed
Papamichael, Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse. 2015, Pubmed
Parente, Behaviour of the bowel wall during the first year after surgery is a strong predictor of symptomatic recurrence of Crohn's disease: a prospective study. 2004, Pubmed
Paulides, Overcoming Workplace Disability in IBD Patients: An Observational Study. 2020, Pubmed
Pellino, Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis. 2020, Pubmed
Peyrin-Biroulet, Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. 2012, Pubmed
Pineton de Chambrun, Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis. 2020, Pubmed
Plevris, Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities. 2022, Pubmed
Poullenot, Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy. 2016, Pubmed
Rahier, Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. 2014, Pubmed
Raine, ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. 2022, Pubmed
Raine, Breaking Through the Therapeutic Ceiling: What Will It Take? 2022, Pubmed
Ramos, IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study. 2015, Pubmed
Rath, Molecular imaging of mucosal α4β7 integrin expression with the fluorescent anti-adhesion antibody vedolizumab in Crohn's disease. 2017, Pubmed
Revés, Unmet needs in inflammatory bowel disease. 2021, Pubmed
Roblin, Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease. 2017, Pubmed
Roda, Crohn's disease. 2020, Pubmed
Rubin, Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians. 2021, Pubmed
Rubin, 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. 2014, Pubmed
Rutgeerts, Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. 2012, Pubmed
Rutgeerts, Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. 2006, Pubmed
Rutgeerts, Predictability of the postoperative course of Crohn's disease. 1990, Pubmed
Ryan, Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa. 2012, Pubmed
Sager, Review article: cytomegalovirus and inflammatory bowel disease. 2015, Pubmed
Salliot, Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. 2009, Pubmed
Sampietro, Sequential Approach for a Critical-View COlectomy (SACCO): A Laparoscopic Technique to Reduce Operative Time and Complications in IBD Acute Severe Colitis. 2020, Pubmed
Sampietro, A prospective, longitudinal study of nonconventional strictureplasty in Crohn's disease. 2004, Pubmed
Sampietro, Prospective study of long-term results and prognostic factors after conservative surgery for small bowel Crohn's disease. 2009, Pubmed
Sampietro, Prevalence and significance of mesentery thickening and lymph nodes enlargement in Crohn's disease. 2022, Pubmed
Sandborn, Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies. 2021, Pubmed
Sandborn, Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0 years of treatment. 2022, Pubmed
Sandborn, Vedolizumab as induction and maintenance therapy for Crohn's disease. 2013, Pubmed
Sands, Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. 2019, Pubmed
Sands, Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. 2019, Pubmed
Sazonovs, HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease. 2020, Pubmed
Shafer, Health Care Indicators of Moderate to Severe IBD and Subsequent IBD-Related Disability: A Longitudinal Study. 2019, Pubmed
Shah, Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease. 2016, Pubmed
Shelton, Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis. 2016, Pubmed
Siegel, SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. 2021, Pubmed
Sinclair, Human cytomegalovirus: Latency and reactivation in the myeloid lineage. 2008, Pubmed
Singh, Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. 2014, Pubmed
Singh, Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. 2021, Pubmed
Singh, Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT. 2019, Pubmed
Sokol, Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease. 2012, Pubmed
Spinelli, ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment. 2022, Pubmed
Stidham, Performance of a Deep Learning Model vs Human Reviewers in Grading Endoscopic Disease Severity of Patients With Ulcerative Colitis. 2019, Pubmed
Sylwester, Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. 2005, Pubmed
Taft, A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease. 2016, Pubmed
Taft, Impact of perceived stigma on inflammatory bowel disease patient outcomes. 2009, Pubmed
Takenaka, Deep Neural Network Accurately Predicts Prognosis of Ulcerative Colitis Using Endoscopic Images. 2021, Pubmed
Tannoury, Determinants of IBD-related disability: a cross-sectional survey from the GETAID. 2021, Pubmed
Tham, Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis. 2018, Pubmed
Thorley-Lawson, The pathogenesis of Epstein-Barr virus persistent infection. 2013, Pubmed
Tibble, Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. 2000, Pubmed
Tontini, Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons. 2021, Pubmed
Torres, ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. 2020, Pubmed
Torres, Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. 2016, Pubmed
Toruner, Risk factors for opportunistic infections in patients with inflammatory bowel disease. 2008, Pubmed
Vedamurthy, Vedolizumab or Tumor Necrosis Factor Antagonist Use and Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease With Prior Malignancy: A Retrospective Cohort Study. 2022, Pubmed
Vega, Cytomegalovirus infection in patients with inflammatory bowel disease. 1999, Pubmed
Verstockt, Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease. 2019, Pubmed
Verstockt, How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments? 2022, Pubmed
Verstockt, Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy. 2021, Pubmed
Vogl, Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation. 2012, Pubmed
Williams, Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease. 2014, Pubmed
Wils, Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. 2021, Pubmed
Winthrop, Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. 2018, Pubmed
Wright, Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery. 2015, Pubmed
Yanai, Epstein-Barr virus infection of the colon with inflammatory bowel disease. 1999, Pubmed
Yao, Automated Detection of Non-Informative Frames for Colonoscopy Through a Combination of Deep Learning and Feature Extraction. 2019, Pubmed
Zolnierek, Physician communication and patient adherence to treatment: a meta-analysis. 2009, Pubmed
de León-Rendón, Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations. 2020, Pubmed
van Gennep, Impaired Quality of Working Life in Inflammatory Bowel Disease Patients. 2021, Pubmed
van der Woude, The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. 2015, Pubmed
Øresland, European evidence based consensus on surgery for ulcerative colitis. 2015, Pubmed